ArticleJournal for immunotherapy of cancer2023

Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses.

Amrendra Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.